RAPGEF5 and intrahepatic cholangiocarcinoma: We found that Circ-RAPGEF5 is distributed in both the cytoplasm and nucleus of ICC cells and has a longer half-life and stronger resistance to RNase R compared with linear mRNA of RAPGE5 and GAPDH.